Thomas J. Benson
Management
Bob, on the Healthcare/Home Environment, as you pointed out, we had a very strong quarter, 20.4% sales growth, which is approximately $23 million. We had very good performance in thermometry. We had good performance in humidifiers. In Europe, we had very warm weather, and we actually sold out of all the fans we had, so we're very pleased with that. And also, our hot/cold therapy, we performed better. The 20% quarterly year-over-year growth rate is not something that we expect as a continuing growth rate. Some of it have to do with the weather. There's possibly some correlation, because we moved warehouses at the end of August, and we did give our customers notes we're moving. We can't say for sure, but maybe some of the customers ordered, a fear of some type of shipping disruption. But as we go into the second half of the year, we are very dependent upon the cough/cold/flu season. We're anticipating a normal cough/cold/flu season. Last year, the cough/cold/flu season started very strong in the November, December, January period. Then it kind of slowed down. So throughout the whole year, it was a normal seasonal. So we're expecting the same type of normal season. On the Personal Care, it was a very good performance, core growth, 3.4%. Looking at the history of the company, that's an area that we've been working on to improve and improve core growth. We do have another favorable event coming out at our European operations. We have an agreement to supply a product for like a 1-year period. During this fiscal year, we have an agreement to sell it. As far as we know, right now, that's not going to continue, so that did have some positive impact on us. We are working on various things to replace those sales for the next fiscal year. But at this time, we know some of them aren't going to continue.